A Delaware biotechnology company, locked in a trade secrets dispute with one of the state’s top research institutions, owns all of the technology its former partner developed for more than a decade, the Court of Chancery ruled last week.
Vice Chancellor Tamika Montgomery-Reeves’ ruling settled a “threshold question” in a case in which Delaware-based iBio Inc. accuses nonprofit Fraunhofer USA of breach of contract and sharing its trade secrets with a competitor.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
